Showing 1671-1680 of 2494 results for "".
- Oyster Point Pharma Announces Tyrvaya Nasal Spray Now Covered by Express Scriptshttps://modernod.com/news/oyster-point-pharma-announces-tyrvaya-nasal-spray-now-covered-by-express-scripts/2480656/Oyster Point Pharma announced Tyrvaya Nasal Spray’s placement on the Express Scripts National Preferred, Basic, and High Performance Formularies, which collectively covers an estimated 26 million people, effective February 19, 2022. Tyrvaya is the first and only na
- Hovione Completes Phase 2 Clinical Trial of First Minocycline Ophthalmic for Dry Eye Disease Associated With Inflamed MGDhttps://modernod.com/news/hovione-completes-phase-2-clinical-trial-of-first-minocycline-ophthalmic-showing-promise-in-dry-eye-disease-associated-with-inflamed-mgd/2478986/Hovione announced at the Ophthalmology Innovation Summit (OIS) Dry Eye Showcase the successful completion of its phase 2 clinical trial in 270 patients with dry eye caused by Meibomian Gland Dysfunction (MGD). The well controlled and representative study was conducted across 26 clinical sites in
- Novavax’s COVID-19 Vaccine Over 89% Effective in UK trial, Less So in South Africa Studyhttps://modernod.com/news/novavaxs-covid-19-vaccine-over-89-effective-in-uk-trial-less-so-in-south-africa-study/2478809/Novavax shares gained as much as 26% on Thursday after the company said its protein-based COVID-19 vaccine candidate NVX-CoV2373 met the primary endpoint of a phase 3 trial in the UK, demonstrating an efficacy rate of over 89%, with high protection also seen against the fast-spreading UK variant.
- FDA Accepts Santen’s NDA for Cyclosporine Topical Ophthalmic Emulsion for the Treatment of Severe Vernal Keratoconjunctivitis in Patients Ages 4-18https://modernod.com/news/fda-accepts-santens-nda-for-cyclosporine-topical-ophthalmic-emulsion-for-the-treatment-of-severe-vernal-keratoconjunctivitis-in-patients-ages-4-18/2478457/Santen announced that the FDA has accepted the new drug application (NDA) for cyclosporine topical ophthalmic emulsion 0.1% for the treatment of severe vernal keratoconjunctivitis (VKC) in patients ages 4-18. The FDA has set June 26, 2021 as the Prescription Drug Use
- Bausch + Lomb Introduces Pinnacle 360 25-Gauge Scleral Fixation Forcepshttps://modernod.com/news/bausch-lomb-introduces-pinnacle-360-25-gauge-scleral-fixation-forceps/2478053/Bausch + Lomb announced the introduction of the new Pinnacle 360 25-gauge Scleral Fixation Forceps. Bausch + Lomb will feature this innovation, as well as others in the company’s retina portfolio, during the virtual American Society of Retinal Specialists (ASRS) annual meeting, July 24-26, 2020.<
- Working With BARDA and FDA on COVID-19 Countermeasureshttps://modernod.com/news/covid-19-working-with-barda-and-fda-on-covid-19-countermeasures/2477443/How can biotech and pharmaceutical companies work with the government in developing and supplying effective diagnostics, treatments and vaccines for COVID-19? What should these companies know? Join Arnold & Porter on Thursday, March 26 from 12–2 pm Eastern Time for an introduction to c
- Fifteenth Annual Eyes on Capitol Hill Advocacy Eventhttps://modernod.com/news/fifteenth-annual-eyes-on-capitol-hill-advocacy-event/2477302/Prevent Blindness will be holding its 15th annual “Eyes on Capitol Hill” advocacy day on February 26, 2020, in Washington, D.C. The annual program provides those from across the United States the opportunity to meet with Congressional and Senate members, and their staff, to discuss vision issues
- Pioneering Ophthalmologist Spencer P. Thornton, MD, Dies at Age 90https://modernod.com/news/pioneering-ophthalmologist-spencer-p-thornton-md-dies-at-age-90/2477074/Spencer P. Thornton, MD, died at age 90 on October 26, 2019. A pioneer in the field of refractive surgery, Dr. Thornton served as the president of the ASCRS from 1997 to 1999 and received the society’s lifetime achievement award earlier this year. He was an internationally recognized speaker and
- Bausch + Lomb Announces New Scientific Analyses Featuring Surgical And Pharmaceutical Products Will Be Presented During ASCRShttps://modernod.com/news/bausch-lomb-announces-new-scientific-analyses-featuring-surgical-and-pharmaceutical-products-will-be-presented-during-ascrs/2476509/Bausch + Lomb announced that 26 new scientific analyses, including 23 podium presentations and three posters, will feature the company’s surgical and pharmaceutical products during the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting in San Diego from
- Ellex to Host an AMD Roundtable During AAO 2018https://modernod.com/news/ellex-to-host-an-amd-roundtable-during-aao-2018/2479760/Ellex Medical Lasers Limited announced that it will partner with a panel of leading ophthalmologists to host a roundtable on age-related macular degeneration (AMD) on Friday, October 26, during the American Academy of Ophthalmology (AAO) meeting in Chicago. “Our goal is to start a serious